Answer Addiction

Tag: opioid dependency

  • Discontinuing Opioids Too Quickly Can Be Harmful, FDA Warns

    Discontinuing Opioids Too Quickly Can Be Harmful, FDA Warns

    The FDA issued guidance to help address the issue of opioid-dependent patients discontinuing or tapering off too quickly and becoming sick. 

    Since the national crackdown on prescription opioids, many pain patients have been forced to taper their dose of painkillers. Now, the Food and Drug Administration is warning doctors that tapering too quickly can have unintended and dangerous consequences. 

    “The U.S. Food and Drug Administration (FDA) has received reports of serious harm in patients who are physically dependent on opioid pain medicines suddenly having these medicines discontinued or the dose rapidly decreased,” the agency said in a statement. “These include serious withdrawal symptoms, uncontrolled pain, psychological distress, and suicide.”

    The FDA issued guidance to help address the problem. 

    “These changes will provide expanded guidance to health care professionals on how to safely decrease the dose in patients who are physically dependent on opioid pain medicines when the dose is to be decreased or the medicine is to be discontinued,” the agency wrote. 

    The agency said that providers should make an individualized plan for patients who need to taper off opioids, and should never stop the pain pills suddenly. The plan should take into consideration the type of opioid and dosage, as well as the patient’s pain and psychological concerns. 

    “Create a patient-specific plan to gradually taper the dose of the opioid and ensure ongoing monitoring and support, as needed, to avoid serious withdrawal symptoms, worsening of the patient’s pain, or psychological distress,” the FDA wrote. 

    The agency also warned that patients should not discontinue opioids without talking to their providers. They should be candid about any side effects they have as their dose of opioids is being tapered. 

    “Even when the opioid dose is decreased gradually, you may experience symptoms of withdrawal,” the agency warned. “Contact your health care professional if you experience increased pain, withdrawal symptoms, changes in your mood, or thoughts of suicide.”

    Although many public health officials applaud efforts to reduce the amount of opioids prescribed, pain patients say that the regulations have gone too far, and have left vulnerable pain patients unprotected. 

    Speaking with The Fix last fall, Lauren DeLuca, a pain patient and founder of the Chronic Illness Advocacy and Awareness Group, said that not being able to access pain medications can be devastating for patients. She said she regularly hears from pain patients who are not able to access enough medications to alleviate their symptoms. Sometimes, these people begin to consider suicide.

    “It is borderline genocide,” she said. “You are allowing them to go home and essentially suffer until they kill themselves.”

    View the original article at thefix.com

  • Lawsuits Aim To Benefit Kids Born Dependent On Opioids

    Lawsuits Aim To Benefit Kids Born Dependent On Opioids

    One West Virginia law firm is reviewing up to 200 cases of children born with neonatal abstinence syndrome (NAS). 

    Last year, dozens of lawsuits were filed against pharmaceutical manufacturers and distributors for the role they play in the opioid crisis.

    Many were filed by states and cities in an attempt to recoup the costs they’ve shouldered as the result of what they say were irresponsible prescribing and misleading marketing of opioid pain pills. 

    Now, a movement is at hand to try to recoup damages for the hundreds of infants born dependent on opioids, many of whom will have life-long health affects. 

    “I really think that we lose the real human toll that the opioid crisis has taken if we’re not bringing cases on behalf of actual human beings who were victimized by the flood of pills that were pumped in here,” Booth Goodwin, an attorney in Charleston, West Virginia, told The Charleston Gazette-Mail.

    Goodwin’s firm, Goodwin & Goodwin LLP, is reviewing up to 200 cases of children born with neonatal abstinence syndrome (NAS). 

    Goodwin has already lodged a lawsuit on behalf of Andriana Riling, an 11-year-old from West Virginia who has NAS and is being raised by her grandparents.

    “Her case is just kind of typical for what you hear from throughout Southern West Virginia,” Goodwin said. “She lost her father even before she was born in a drug-related car accident. Her birth mother is hopelessly addicted to pills and opioids in general.”

    The lawsuit alleges that Purdue Pharma, Endo Health Solutions and Pharmaceuticals, McKesson Corp., Cardinal Health, AmerisourceBergen and Mallinckrodt all bear responsibility for Riling’s condition for their role in making and distributing the opioids that Riling’s mother took during her pregnancy. 

    Although most of the lawsuits against the opioid manufacturers and distributors have been lumped together under the jurisdiction of a federal judge in Cleveland, Ohio, Goodwin argues that cases involving children with NAS should remain separate so that the unique details of each case can be shown, rather than lumping them together in a class action suit. 

    “Each one of them is affected a little bit different,” he said. “And we want to make sure that we focus on each one of these individual children.”

    He said that the individual cases will focus more on the specific ways these children have been affected by the practices of the companies that are named as defendants. The federal case in Ohio will focus more on the overarching — and perhaps illegal — practices that companies had in place. Because of that, Goodwin’s firm filed a motion to keep Riling’s case from being combined with the Cleveland cases. 

    “The complaint contains very specific allegations, unique to this case, with respect to prescribing doctors and pharmacies,” attorneys wrote when they requested that the case be heard separately. “Although there are generalized facts at issue in both [the Cleveland cases] and the Rilings’ case regarding the reprehensible conduct of the defendants, this overlap is minor.”

    They continued, “[The Cleveland cases] potentially involve comparative fault on the part of the plaintiffs, while Riling, a child born opioid dependent, is an innocent victim who is inherently and completely blameless.”

    While Goodwin waits to hear whether the case will be heard on its own, his law firm is continuing to look for children with NAS, which affected up to 5% of births in West Virginia during the peak years of the opioid epidemic. 

    View the original article at thefix.com